Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed5

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT05611905Completed
Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid
Bacterial InfectionsInflammatory DiseaseOncologic Disease+1 more
PrincipalinvestigatorStart date: 2023-12-22
NCT05611892Completed
Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients
Enterobacterial InfectionsInflammatory DiseaseInvasive Fungal Infections+1 more
PrincipalinvestigatorStart date: 2022-12-22
NCT04377672Phase 1Completed
Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)
SARS-CoV-2 Infection
PrincipalinvestigatorStart date: 2020-05-28
NCT03428776Not ApplicableCompleted
Timeliness of Immunization and Compliance Assessment Study
Vaccinations
PrincipalinvestigatorStart date: 2018-04-25
NCT03180138Not ApplicableCompleted
Enhancing Health Care Access With Cellular Technology
Vaccination
PrincipalinvestigatorStart date: 2016-07-11

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT05611905PrincipalInvestigator

Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid

Bacterial InfectionsInflammatory DiseaseOncologic Disease+1 more
Completed
NCT05611892PrincipalInvestigator

Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients

Enterobacterial InfectionsInflammatory DiseaseInvasive Fungal Infections+1 more
Completed
NCT04377672Phase 1PrincipalInvestigator

Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)

SARS-CoV-2 Infection
Completed
NCT03428776Not ApplicablePrincipalInvestigator

Timeliness of Immunization and Compliance Assessment Study

Vaccinations
Completed
NCT03180138Not ApplicablePrincipalInvestigator

Enhancing Health Care Access With Cellular Technology

Vaccination
Completed

All 5 trials loaded